Structural mapping of Mycobacterium leprae to understand pathogenesis and advance therapeutic discovery; a mini review

Mycobacterium leprae is an obligate intracellular, acid-fast bacillus and the primary causative agent of leprosy (Hansen’s disease), a chronic infection that predominantly affects the skin, peripheral nerves, upper respiratory mucosa, and eyes. Despite multi-drug therapy, more than 200,000 new cases are reported globally each year, reflecting continued transmission in endemic regions. Understanding Mycobacterium leprae biology remains challenging because of its highly reduced genome, inability to be cultured in conventional in vitro systems, and limited experimental tractability. Of the 1,614 annotated genes expressed in M. leprae, structures for around 17 proteins are currently available in the Protein Data Bank, compared with approximately 1,277 entries for Mycobacterium tuberculosis. This marked disparity represents a major structural knowledge gap, limiting direct mechanistic interpretation of M. leprae protein function, drug-target interactions, and resistance-associated changes and often necessitating inference from related mycobacteria. Recent advances in structural biology and computational modelling provide complementary means of addressing this gap. In this mini-review, we highlight structural characterisation of key M. leprae proteins involved in metabolism, cellular stress, and genome maintenance, advances in structure-based drug discovery, and the application of computational methods to expand structural knowledge and investigate protein function, drug binding, and resistance. We also discuss progress and emerging opportunities in structure-guided therapeutic and vaccine development, and the potential of integrating structural insights with multi-omics and experimental approaches. Structural mapping can therefore bridge key knowledge gaps in M. leprae biology, elucidate mechanisms underlying pathogenesis and drug response, and guide targeted therapeutic strategies for improved leprosy control and elimination.

Authors

Institutions

Publication Details

Journal
Frontiers in Chemistry
Published
2026-11-17
DOI
https://doi.org/10.3389/fchem.2026.1954624
Primary Topic
Leprosy Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Structural mapping of Mycobacterium leprae to understand pathogenesis and advance therapeutic discovery; a mini review

Stella Irungu, Clare Njoki Kimani, Ngalla Jillani, Lewis Mungoma Ngalla et al.
Frontiers in Chemistry
Leprosy Research and Treatment
article

Structural mapping of Mycobacterium leprae to understand pathogenesis and advance therapeutic discovery; a mini review

Stella Irungu, Clare Njoki Kimani, Ngalla Jillani, Lewis Mungoma Ngalla, Lywellyn Chahale Imbahale, Myles Mvera Fafali
article en

Abstract

Mycobacterium leprae is an obligate intracellular, acid-fast bacillus and the primary causative agent of leprosy (Hansen’s disease), a chronic infection that predominantly affects the skin, peripheral nerves, upper respiratory mucosa, and eyes. Despite multi-drug therapy, more than 200,000 new cases are reported globally each year, reflecting continued transmission in endemic regions. Understanding Mycobacterium leprae biology remains challenging because of its highly reduced genome, inability to be cultured in conventional in vitro systems, and limited experimental tractability. Of the 1,614 annotated genes expressed in M. leprae, structures for around 17 proteins are currently available in the Protein Data Bank, compared with approximately 1,277 entries for Mycobacterium tuberculosis. This marked disparity represents a major structural knowledge gap, limiting direct mechanistic interpretation of M. leprae protein function, drug-target interactions, and resistance-associated changes and often necessitating inference from related mycobacteria. Recent advances in structural biology and computational modelling provide complementary means of addressing this gap. In this mini-review, we highlight structural characterisation of key M. leprae proteins involved in metabolism, cellular stress, and genome maintenance, advances in structure-based drug discovery, and the application of computational methods to expand structural knowledge and investigate protein function, drug binding, and resistance. We also discuss progress and emerging opportunities in structure-guided therapeutic and vaccine development, and the potential of integrating structural insights with multi-omics and experimental approaches. Structural mapping can therefore bridge key knowledge gaps in M. leprae biology, elucidate mechanisms underlying pathogenesis and drug response, and guide targeted therapeutic strategies for improved leprosy control and elimination.

Frontiers in ChemistryVol. 14
Institute of Primate Research (KE)
Good health and well-being
Leprosy Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon